表紙
市場調査レポート

小細胞性肺癌:世界の治験動向

Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 229163
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
小細胞性肺癌:世界の治験動向 Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015
出版日: 2015年08月19日 ページ情報: 英文 121 Pages
概要

当レポートでは、小細胞性肺癌に関する臨床研究の最新動向について分析し、疾患の概要をはじめ、地域および主要国における治験の状況、フェーズ(相)・進捗状況別の治験データ、被験者の募集状況、有望なスポンサー、そして各企業・研究機関の治験プロファイルなどの情報を盛り込んでお届けします。

目次

イントロダクション

  • 小細胞性肺癌
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域
    • 上位5ヶ国における治験件数; 中南米

G7諸国における治験件数: 小細胞性肺癌治験件数の腫瘍治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数: 小細胞性肺癌治験件数の腫瘍治験件数に対する比率

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - 小細胞性肺癌治療薬

有望な薬剤

  • 最新治験ニュース: 小細胞性肺癌

治験のプロファイル

  • 代表的な企業の治験の概要
    • GlaxoSmithKline Plc
    • Eli Lilly and Company
    • Novartis AG
    • Bristol-Myers Squibb Company
    • AstraZeneca Plc
    • Sanofi
    • Pfizer Inc.
    • Celgene Corporation
    • F. Hoffmann-La Roche Ltd.
    • Bayer AG
  • 代表的な研究機関/病院の治験の概要
    • National Cancer Institute
    • European Organization for Research and Treatment of Cancer
    • Sarah Cannon Research Institute
    • Case Comprehensive Cancer Center
    • Hoosier Cancer Research Network
    • Maastricht Radiation Oncology
    • Medical Research Council
    • Japan Clinical Oncology Group
    • National Cancer Center
    • NCIC Clinical Trials Group

5大治験プロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2827CTIDB

GlobalData's clinical trial report, "Small-Cell Lung Cancer Global Clinical Trials Review, H2, 2015" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Small-Cell Lung Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Small-Cell Lung Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Small-Cell Lung Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Small-Cell Lung Cancer Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Small-Cell Lung Cancer
      • May 28, 2015: OncoMed Pharmaceuticals to Review Key ASCO Data for Tarextumab During Conference Call on Tuesday, June 2, 2015
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Sarah Cannon Research Institute
      • Clinical Trial Overview of Sarah Cannon Research Institute
      • Case Comprehensive Cancer Center
      • Clinical Trial Overview of Case Comprehensive Cancer Center
      • Hoosier Cancer Research Network
      • Clinical Trial Overview of Hoosier Cancer Research Network
      • Maastricht Radiation Oncology
      • Clinical Trial Overview of Maastricht Radiation Oncology
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
      • Japan Clinical Oncology Group
      • Clinical Trial Overview of Japan Clinical Oncology Group
      • National Cancer Center
      • Clinical Trial Overview of National Cancer Center
      • NCIC Clinical Trials Group
      • Clinical Trial Overview of NCIC Clinical Trials Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoosier Cancer Research Network, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht Radiation Oncology, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Clinical Oncology Group, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2015*

List of Figures

  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Small-Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Small-Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Small-Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top